Journal article
Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis
Abstract
Background: Atopic dermatitis (AD) is a skin barrier dysfunction characterized by tissue eosinophilia.
Objective: In patients with AD, we evaluated the effect of eosinophil depletion with benralizumab on markers of inflammation in skin after intradermal allergen challenge.
Authors
Whetstone CE; Cusack RP; Price E; Howie K; Stevens C; Al-Sajee D; Beaudin S; Wattie J; Alsaji N; Schlatman A
Journal
Journal of Allergy and Clinical Immunology Global, Vol. 3, No. 4,
Publisher
Elsevier
Publication Date
11 2024
DOI
10.1016/j.jacig.2024.100310
ISSN
2772-8293